[Evaluation of hormone therapy in women during postmenopause with the help of Kliogest].
Seventeen women were observed during a six-month lasting period of replacement hormonotherapy. In all women there appeared decrease in subjective symptoms, as well as decrease in the blood level of FSH and LH and increase in the blood level of estradiol were observed.
Bałajewicz
M
M
Katedry i Kliniki Endokrynologii i Płodności UJ.
Mazanek-Mościcka
M
M
D000328:Adult; D004338:Drug Combinations; D004958:Estradiol / Q000097:blood / Q000627:therapeutic use*; D004964:Estriol / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D009640:Norethindrone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017698:Postmenopause / Q000097:blood / Q000187:drug effects*
D004338:Drug Combinations; D004958:Estradiol; C032040:Trisequens; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D004964:Estriol; D009640:Norethindrone